Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

As a young girl in Kampala, Karmali Rashida would read stories about medicine and the human body. The deep curiosity about healing sparked something in her, a fascination with science that would one ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

The UK government has announced a shift in its nuclear energy policy to approve additional nuclear power plants across ...

Britain on Thursday promised to free more sites for nuclear energy developments across England and Wales, seeking to attract private investment into Small Modular Reactors (SMRs) as part of its push ...

This was the stock's second consecutive day of gains.